Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material
A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Pl...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 1980-05, Vol.18 (3), p.431-437 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 437 |
---|---|
container_issue | 3 |
container_start_page | 431 |
container_title | Thrombosis research |
container_volume | 18 |
creator | Barlow, G.H. Marder, V.J. |
description | A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”. |
doi_str_mv | 10.1016/0049-3848(80)90338-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75260813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0049384880903382</els_id><sourcerecordid>75260813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EKkvhH4DkE4JD2rGdxPYFqar4qFSJHuBsOc4EDElcPHGl_fd42VWPnGak92NGD2OvBVwIEP0lQGsbZVrzzsB7C0qZRj5hO2G0bWSr5VO2e7Q8Zy-IfgEILWx3xs56aw20Ysfy3exp8bzk9DuunpDP-IAz8QU9lYwjH_Y8_MxpST9wjYF7Ir_nftow87hOhWJaiaeJb5GoIA9l3mqOp1w7a2Pec0olB-SLr5no55fs2eRnwlenec6-f_r47fpLc_v188311W0TVKe3prNa6uARoPOdHQdpNEwQEAbVDaP1Qx_CBIhhGqVU42Hz3lscdT-AMlads7fH3vuc_hSkzS2RAs6zXzEVcrqTPRihqrE9GkNORBknd5_jUj93AtwBtTtwdAeOzoD7h9rJGntz6i_DguNj6MS26h-OesWJDxGzoxBxDTjGjGFzY4r_P_AXjMWRfg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75260813</pqid></control><display><type>article</type><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Barlow, G.H. ; Marder, V.J.</creator><creatorcontrib>Barlow, G.H. ; Marder, V.J.</creatorcontrib><description>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(80)90338-2</identifier><identifier>PMID: 6998041</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Chromogenic assay ; Chromogenic Compounds ; Culture Techniques ; Endopeptidases - blood ; Fibrinolysis ; Humans ; Infusions, Parenteral ; Molecular Weight ; plasminogen activator ; therapeutic thrombolysis ; Time Factors ; urokinase ; Urokinase-Type Plasminogen Activator - blood ; Urokinase-Type Plasminogen Activator - urine</subject><ispartof>Thrombosis research, 1980-05, Vol.18 (3), p.431-437</ispartof><rights>1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</citedby><cites>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0049-3848(80)90338-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6998041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barlow, G.H.</creatorcontrib><creatorcontrib>Marder, V.J.</creatorcontrib><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</description><subject>Chromogenic assay</subject><subject>Chromogenic Compounds</subject><subject>Culture Techniques</subject><subject>Endopeptidases - blood</subject><subject>Fibrinolysis</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Molecular Weight</subject><subject>plasminogen activator</subject><subject>therapeutic thrombolysis</subject><subject>Time Factors</subject><subject>urokinase</subject><subject>Urokinase-Type Plasminogen Activator - blood</subject><subject>Urokinase-Type Plasminogen Activator - urine</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EKkvhH4DkE4JD2rGdxPYFqar4qFSJHuBsOc4EDElcPHGl_fd42VWPnGak92NGD2OvBVwIEP0lQGsbZVrzzsB7C0qZRj5hO2G0bWSr5VO2e7Q8Zy-IfgEILWx3xs56aw20Ysfy3exp8bzk9DuunpDP-IAz8QU9lYwjH_Y8_MxpST9wjYF7Ir_nftow87hOhWJaiaeJb5GoIA9l3mqOp1w7a2Pec0olB-SLr5no55fs2eRnwlenec6-f_r47fpLc_v188311W0TVKe3prNa6uARoPOdHQdpNEwQEAbVDaP1Qx_CBIhhGqVU42Hz3lscdT-AMlads7fH3vuc_hSkzS2RAs6zXzEVcrqTPRihqrE9GkNORBknd5_jUj93AtwBtTtwdAeOzoD7h9rJGntz6i_DguNj6MS26h-OesWJDxGzoxBxDTjGjGFzY4r_P_AXjMWRfg</recordid><startdate>19800501</startdate><enddate>19800501</enddate><creator>Barlow, G.H.</creator><creator>Marder, V.J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19800501</creationdate><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><author>Barlow, G.H. ; Marder, V.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Chromogenic assay</topic><topic>Chromogenic Compounds</topic><topic>Culture Techniques</topic><topic>Endopeptidases - blood</topic><topic>Fibrinolysis</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Molecular Weight</topic><topic>plasminogen activator</topic><topic>therapeutic thrombolysis</topic><topic>Time Factors</topic><topic>urokinase</topic><topic>Urokinase-Type Plasminogen Activator - blood</topic><topic>Urokinase-Type Plasminogen Activator - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barlow, G.H.</creatorcontrib><creatorcontrib>Marder, V.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barlow, G.H.</au><au>Marder, V.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1980-05-01</date><risdate>1980</risdate><volume>18</volume><issue>3</issue><spage>431</spage><epage>437</epage><pages>431-437</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>6998041</pmid><doi>10.1016/0049-3848(80)90338-2</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 1980-05, Vol.18 (3), p.431-437 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_75260813 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Chromogenic assay Chromogenic Compounds Culture Techniques Endopeptidases - blood Fibrinolysis Humans Infusions, Parenteral Molecular Weight plasminogen activator therapeutic thrombolysis Time Factors urokinase Urokinase-Type Plasminogen Activator - blood Urokinase-Type Plasminogen Activator - urine |
title | Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A23%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20urokinase%20levels%20measured%20by%20chromogenic%20assay%20after%20infusions%20of%20tissue%20culture%20or%20urinary%20source%20material&rft.jtitle=Thrombosis%20research&rft.au=Barlow,%20G.H.&rft.date=1980-05-01&rft.volume=18&rft.issue=3&rft.spage=431&rft.epage=437&rft.pages=431-437&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/0049-3848(80)90338-2&rft_dat=%3Cproquest_cross%3E75260813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75260813&rft_id=info:pmid/6998041&rft_els_id=0049384880903382&rfr_iscdi=true |